1-[9-(3,3-Diphenylprop-2-enyl)-3,9-diazabicyclo[4.2.1]nonan-3-yl]propan-1-one | 1207071-52-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-[9-(3,3-Diphenylprop-2-enyl)-3,9-diazabicyclo[4.2.1]nonan-3-yl]propan-1-one
• CAS: 1207071-52-0
• 化学式: C₂₅H₃₀N₂O
• 分子量: 374.526
• InChiKey: KPMUQFZAOQBQJI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  28
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  23.6
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• Diazabicyclic compounds and microemulsions thereof
  申请人：Neuroscienze Pharmaness S.C. A R.L.

  公开号：EP2149370A1

  公开（公告）日：2010-02-03

  Pharmaceutical compositions in the form of microemulsions comprising the following components, in amounts expressed as % by weight, the sum of the components being 100%: S) from 0.01 to 95% of one or more pharmaceutically acceptable compounds, selected from the following classes: surfactants; polymers forming organized structures as micelles, liquid crystals, vesicles in the liquid in which they are solubilized; O) from 0.01 to 95% of one or more oils, PA) from 0.001 to 90% of diazabicyclic compounds having formula A': wherein t, r, Y, W have the meanings reported in the description, AD) from 0 to 60% by weight of one or more compounds selected from the following classes: - modifiers of water and/or oil polarity, - modifiers of the curvature of the film of component S), - co-surfactants, water from 0.01 to 99.9%.

  微乳剂形式的药物组合物，包括以下成分，按重量百分比表示，各成分之和为100%：S）0.01至95%的一种或多种药用可接受化合物，选自以下类别：表面活性剂；形成有序结构的聚合物，如胶囊、液晶、液体中的囊泡；O）0.01至95%的一种或多种油；PA）0.001至90%的具有A'式的二氮杂双环化合物，其中t、r、Y、W在描述中有所说明；AD）0至60%的一种或多种化合物，选自以下类别：- 调节水和/或油极性的调节剂，- 调节组分S)膜的曲率的调节剂，- 辅助表面活性剂，水0.01至99.9%。
• PHARMACEUTICAL COMPOUNDS
  申请人：LAZZARI Paolo

  公开号：US20100028257A1

  公开（公告）日：2010-02-04

  Nonane and decane diazabicyclic derivatives having homopiperazine as main ring, having affinity for the opioidergic μ and/or δ and/or k receptors and/or for all their receptorial subclasses, with central and/or peripheral activity, having formula (I), the isomeric forms and their mixtures included, wherein one or more atoms are in the corresponding isotopic forms: wherein: n is an integer equal to 1 or 2; one of the substituents R and R 1 of the nitrogen atoms of the diazabicyclic ring is a —C(O)—R B group; wherein R B is a C 1 -C 10 alkyl group, linear or branched when possible, the other remained substituent of R and R 1 has the meanings reported in the description.

  具有同环吡哌啉作为主环的壬烷和癸烷二氮杂双环衍生物，具有对μ和/或δ和/或κ阿片受体以及/或其所有受体亚类的亲和力，具有中枢和/或外周活性，具有式(I)的化学式，包括同分异构体和它们的混合物，其中一个或多个原子以相应的同位素形式存在： 其中： n是等于1或2的整数； 二氮杂双环环的氮原子的取代基R和R1中的一个是—C(O)—RB基团；其中RB是C1-C10烷基基团，线性或支链形式； R和R1的另一个保留的取代基具有描述中所报告的含义。
• MICROEMULSIONS
  申请人：LAZZARI Paolo

  公开号：US20100029622A1

  公开（公告）日：2010-02-04

  Pharmaceutical compositions in the form of microemulsions comprising the following components, in amounts expressed as % by weight, the sum of the components being 100%: S) from 0.01 to 95% of one or more pharmaceutically acceptable compounds, selected from the following classes: surfactants; polymers forming organized structures as micelles, liquid crystals, vesicles in the liquid in which they are solubilized; 0) from 0.01 to 95% of one or more oils, PA) from 0.001 to 90% of diazabicyclic compounds having formula A′: wherein t, r, Y, W have the meanings reported in the description, AD) from 0 to 60% by weight of one or more compounds selected from the following classes: modifiers of water and/or oil polarity, modifiers of the curvature of the film of component S), co-surfactants, water from 0.01 to 99.9%.

  微乳剂形式的药物组合物，包括以下成分，按重量百分比表示，各成分之和为100%:S) 0.01至95%的一个或多个药用可接受化合物，从以下类别中选择：表面活性剂；形成有序结构的聚合物，如胶束、液晶、液滴，它们在所溶解的液体中；0) 0.01至95%的一个或多个油；PA) 具有A′式的二氮杂双环化合物，其含量为0.001至90%，其中t、r、Y、W的含义如描述中所述；AD) 0至60%的一个或多个化合物，选择自以下类别：调节水和/或油极性的调节剂，调节成分S)膜的曲率的调节剂，共表面活性剂，水含量为0.01至99.9%。
• Diazabicyclic compounds as opioid receptor agonists
  申请人：Neuroscienze Pharmaness S.C. A R.L.

  公开号：EP2149575B1

  公开（公告）日：2012-10-24
• US8399457B2
  申请人：——

  公开号：US8399457B2

  公开（公告）日：2013-03-19